CVS Health (NYSE:CVS) Rating Lowered to “Buy” at Wall Street Zen

CVS Health (NYSE:CVS) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Other analysts have also issued research reports about the company. Mizuho raised their target price on CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Wells Fargo & Company upped their price target on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. UBS Group lowered their price objective on shares of CVS Health from $126.00 to $118.00 and set a “buy” rating on the stock in a research note on Thursday, September 3rd. Finally, JPMorgan Chase & Co. upped their target price on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Twenty-two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.24.

CVS Health Stock Performance

NYSE:CVS opened at $94.62 on Friday. The firm has a market capitalization of $121.02 billion, a PE ratio of 25.03, a PEG ratio of 0.92 and a beta of 0.59. CVS Health has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $99.92 and its 200 day simple moving average is $90.86.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts anticipate that CVS Health will post 8.02 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. California State Teachers Retirement System lifted its holdings in shares of CVS Health by 10,133.9% during the 2nd quarter. California State Teachers Retirement System now owns 193,320,429 shares of the pharmacy operator’s stock worth $19,998,998,000 after acquiring an additional 191,431,405 shares during the period. BlackRock Inc. acquired a new position in CVS Health in the second quarter worth about $12,747,462,000. State Street Corp raised its position in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after purchasing an additional 1,245,457 shares in the last quarter. Wellington Management Group LLP lifted its stake in CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the period. Finally, Capital International Investors boosted its holdings in CVS Health by 3.4% during the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after purchasing an additional 900,153 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Company Profile

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.